These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36726065)

  • 21. Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients.
    Lee SM; Chung SJ; Lew H
    Korean J Ophthalmol; 2018 Dec; 32(6):445-450. PubMed ID: 30549467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the effects of ocular nebulization combined with meibomian gland massage on ocular surface status and corneal higher-order aberrations for the treatment of meibomian gland dysfunction.
    Lin F; Mao X; Ma L; Liu H
    Acta Ophthalmol; 2022 May; 100(3):e681-e693. PubMed ID: 34331838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ
    Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are inflammation-related diseases risk factors for primary acquired nasolacrimal duct obstruction? A large scale, national case-control study.
    Kerber L; Kerman T; Hazan I; Ziv O; Kordelul S; Tsumi E
    Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1911-1917. PubMed ID: 38194111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method.
    Park DI; Lew H; Lee SY
    Acta Ophthalmol; 2012 Dec; 90(8):783-7. PubMed ID: 21726426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular surface changes and discomfort in patients with meibomian gland dysfunction.
    Shimazaki J; Sakata M; Tsubota K
    Arch Ophthalmol; 1995 Oct; 113(10):1266-70. PubMed ID: 7575257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasolacrimal canal morphology with or without idiopathic obstruction in Caucasian adults: a multidetector CT study.
    Ulutas HG; Yazici B; Ulutas E; Yazici Z
    Int Ophthalmol; 2022 Jun; 42(6):1727-1735. PubMed ID: 35079938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of pH, electrolytes and electrophoretic studies of tear proteins in tears of patients with dacryoliths: a novel concept for dacryoliths.
    Lew H; Lee SY; Yun YS
    Ophthalmologica; 2004; 218(2):130-5. PubMed ID: 15004503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessments of the ocular surface and meibomian gland morphology in patients with treatment-naive acne vulgaris.
    Koca S; Oral AY
    Arq Bras Oftalmol; 2023; 86(2):145-150. PubMed ID: 35417517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of meibomian glands and tear film in post-refractive surgery patients.
    Jung JW; Kim JY; Chin HS; Suh YJ; Kim TI; Seo KY
    Clin Exp Ophthalmol; 2017 Dec; 45(9):857-866. PubMed ID: 28544605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meibomian glands structure in daily disposable soft contact lens wearers: a one-year follow-up study.
    Llorens-Quintana C; Garaszczuk IK; Szczesna-Iskander DH
    Ophthalmic Physiol Opt; 2020 Sep; 40(5):607-616. PubMed ID: 32716128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.
    Lee SM; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):173-180. PubMed ID: 32743774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.
    Zang S; Cui Y; Cui Y; Fei W
    Eye (Lond); 2018 Nov; 32(11):1681-1687. PubMed ID: 29934634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relationship between Primary Acquired Nasolacrimal Duct Obstruction and Gastroesophageal Reflux.
    Owji N; Radaei M; Khademi B
    Curr Eye Res; 2018 Oct; 43(10):1239-1243. PubMed ID: 29897254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction.
    Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Influence of Overnight Orthokeratology on Ocular Surface and Meibomian Glands in Children and Adolescents.
    Na KS; Yoo YS; Hwang HS; Mok JW; Kim HS; Joo CK
    Eye Contact Lens; 2016 Jan; 42(1):68-73. PubMed ID: 26629959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of both lacrimal glands in unilateral primary acquired nasolacrimal duct obstruction, based on three-dimensional fast spin echo-Cube-Flex.
    Zhao Y; Tian M; Luo B; Liang W; Wu H; Wang Q; Zhang J
    Eur J Radiol; 2022 Nov; 156():110517. PubMed ID: 36108476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meibomian gland dysfunction in patients with Sjögren syndrome.
    Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
    Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of congenital and developmental cataract surgery on the ocular surface in a six-month follow-up prospective clinical study.
    Lin X; Li H; Zhou X; Liu X; Fan F; Yang T; Luo Y
    BMC Ophthalmol; 2022 May; 22(1):218. PubMed ID: 35562718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.